Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI (Infectious Diseases and Therapy, (2024), 13, 10, (2105-2121), 10.1007/s40121-024-01007-z)

on behalf of the ECOSPOR III and ECOSPOR IV investigators

Research output: Contribution to journalComment/debate

Abstract

The authors noticed errors in the online supplementary material (mislabeling of tables) after online publication. Both Tables 12 and 13 have the same title, and although Table 13 lists out IRBs, it’s titled as Table 12. This has been corrected in the online supplementary material.

Original languageEnglish
Pages (from-to)2209-2210
Number of pages2
JournalInfectious Diseases and Therapy
Volume13
Issue number10
DOIs
StatePublished - Oct 2024

Cite this